Research Institute of Molecular Pathology (IMP)
Darja Kordic has extensive experience in molecular biology and biochemistry, currently serving as a Predoctoral Fellow and PhD Student at the Research Institute of Molecular Pathology since September 2017. Prior roles include serving as an Undergraduate Researcher at the same institute and working as a Content Editor at Ciuvo GmbH from February 2016 to August 2017, as well as a Project Assistant at Adverity between October 2014 and February 2016. Darja Kordic earned a Doctor of Philosophy in Biochemistry and Structural Biology from the University of Vienna from January 2019 to February 2023, a Master of Science in Molecular Biology and Biochemistry from October 2016 to January 2019, and a Bachelor of Science in Molecular Biology from March 2012 to October 2016.
Research Institute of Molecular Pathology (IMP)
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology.